D.E. Shaw & Co’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.69M Buy
429,332
+396,336
+1,201% +$9.1M 0.01% 1668
2025
Q4
$786K Buy
+32,996
New +$821K ﹤0.01% 3682
2024
Q4
Sell
-14,340
Closed -$305K 4541
2024
Q3
$305K Buy
+14,340
New +$282K ﹤0.01% 3966
2024
Q2
Sell
-76,176
Closed -$1.47M 4598
2024
Q1
$1.47M Buy
76,176
+60,831
+396% +$1.21M ﹤0.01% 2844
2023
Q4
$320K Buy
+15,345
New +$295K ﹤0.01% 3722
2022
Q4
Sell
-120,069
Closed -$1.69M 4933
2022
Q3
$1.69M Buy
+120,069
New +$2.27M ﹤0.01% 3145
2022
Q2
Sell
-70,443
Closed -$2.37M 5467
2022
Q1
$2.37M Sell
70,443
-3,437
-5% -$113K ﹤0.01% 3146
2021
Q4
$2.4M Buy
+73,880
New +$2.43M ﹤0.01% 3192
2021
Q2
Sell
-26,363
Closed -$972K 4831
2021
Q1
$972K Sell
26,363
-35,980
-58% -$1.36M ﹤0.01% 3135
2020
Q4
$2.59M Buy
62,343
+55,152
+767% +$2.3M ﹤0.01% 2383
2020
Q3
$305K Buy
+7,191
New +$310K ﹤0.01% 3440
2020
Q2
Sell
-40,229
Closed -$1.32M 4065
2020
Q1
$1.32M Sell
40,229
-36,176
-47% -$1.34M ﹤0.01% 2511
2019
Q4
$2.81M Buy
76,405
+68,731
+896% +$2.44M ﹤0.01% 2196
2019
Q3
$258K Sell
7,674
-5,510
-42% -$195K ﹤0.01% 3526
2019
Q2
$518K Sell
13,184
-826
-6% -$32.7K ﹤0.01% 3060
2019
Q1
$568K Sell
14,010
-197,754
-93% -$7.37M ﹤0.01% 2926
2018
Q4
$6.86M Buy
211,764
+180,445
+576% +$7.28M 0.01% 1332
2018
Q3
$1.61M Buy
+31,319
New +$1.57M ﹤0.01% 2353
2018
Q2
Sell
-28,136
Closed -$1.44M 3753
2018
Q1
$1.44M Buy
28,136
+10,963
+64% +$585K ﹤0.01% 2260
2017
Q4
$902K Sell
17,173
-25,660
-60% -$1.27M ﹤0.01% 2637
2017
Q3
$2.09M Buy
+42,833
New +$2.04M ﹤0.01% 1986
2017
Q2
Sell
-14,029
Closed -$591K 3418
2017
Q1
$591K Sell
14,029
-77,598
-85% -$3.21M ﹤0.01% 2642
2016
Q4
$3.87M Buy
91,627
+86,000
+1,528% +$3.51M 0.01% 1501
2016
Q3
$246K Sell
5,627
-59,467
-91% -$2.66M ﹤0.01% 3129
2016
Q2
$2.84M Sell
65,094
-49,313
-43% -$2.13M 0.01% 1676
2016
Q1
$5.04M Buy
114,407
+91,260
+394% +$3.86M 0.01% 1270
2015
Q4
$968K Sell
23,147
-658
-3% -$27.7K ﹤0.01% 2650
2015
Q3
$929K Sell
23,805
-10,618
-31% -$432K ﹤0.01% 2648
2015
Q2
$1.43M Sell
34,423
-49,908
-59% -$2.13M ﹤0.01% 2444
2015
Q1
$3.5M Sell
84,331
-61,877
-42% -$2.39M 0.01% 1626
2014
Q4
$5.43M Buy
146,208
+687
+0.5% +$24.8K 0.01% 1510
2014
Q3
$5.05M Sell
145,521
-32,083
-18% -$1.11M 0.01% 1561
2014
Q2
$5.95M Buy
177,604
+84,229
+90% +$2.81M 0.01% 1486
2014
Q1
$3.25M Buy
93,375
+1,324
+1% +$46.4K ﹤0.01% 1922
2013
Q4
$3.27M Sell
92,051
-720
-0.8% -$24.1K ﹤0.01% 2049
2013
Q3
$3M Buy
92,771
+14,138
+18% +$460K ﹤0.01% 2064
2013
Q2
$2.77M Buy
+78,633
New +$2.73M 0.01% 1820

Other funds holding FMS

D.E. Shaw & Co's FMS Position: Q1 2026 in Review

D.E. Shaw & Co increased its Fresenius Medical Care (FMS) stake by 1,201% in Q1 2026, buying an estimated $9.1M and bringing the position to 429,332 shares worth $9.69M. The position accounts for 0.01% of the portfolio, ranked #1668.

D.E. Shaw & Co first reported a position in FMS in Q2 2013 and has held it in 37 quarters since. 218 funds tracked by Wall St. Rank hold FMS as of Q1 2026.

  • D.E. Shaw & Co held 429,332 shares of Fresenius Medical Care worth $9.69M as of Q1 2026.
  • D.E. Shaw & Co bought 396,336 Fresenius Medical Care shares in Q1 2026, an estimated $9.1M.
  • Fresenius Medical Care made up 0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #1668 holding.
  • D.E. Shaw & Co first reported a position in Fresenius Medical Care in Q2 2013 and has held it in 37 quarters since.
  • 218 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.